Skip to main content
. Author manuscript; available in PMC: 2014 Jul 1.
Published in final edited form as: Obesity (Silver Spring). 2013 Jun 11;22(1):292–299. doi: 10.1002/oby.20426

Appendix Figure 2.

Appendix Figure 2

Age-adjusted prevalence (95% confidence interval) for NAFLD* by race and body mass index group among physically active participants (Panel A) and among physically inactive participants (Panel B).

*NAFLD was defined as the presence of moderate or severe hepatic steatosis by ultrasound in the absence of alcohol consumption >1 drink/day for women and >2 drinks/day for men and in the absence of the current use of zydovudine or didanosine, medications shown to induce hepatic steatosis.

† p<0.05 comparing Mexican-Americans to non-Hispanic whites

‡ p<0.05 comparing non-Hispanic blacks to non-Hispanic whites